A Phase 2/3 interventional study of Fecal Microbiota Transplantation in Ulcerative Colitis and Fecal Microbiota Transplantation, sponsored by Jun Liu. Status unknown. Open to male participants aged 25 Years to 60 Years. Per ClinicalTrials.gov, last updated 2015-05-06.
Sponsored by Jun Liu · Phase 2/3, Interventional, and Treatment
The aim of our study is to investigate the efficacy and mechanism in fecal microbiota transplantation in the treatment of ulcerative colitis. About 20 Ulcerative Colitis (UC) patients will be recruited into our trial for Fecal Microbiota Transplantation (FMT) treatment,the safety and efficacy of FMT will be observed.
1,073 studies on the registry are indexed under Colitis; 131 are open to participants now.
This study's planned enrollment of 20 is below the median of 60 across 771 interventional studies indexed under Colitis.
Browse Colitis studies →Jun Liu is the lead sponsor of 3 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Biological: Fecal Microbiota Transplantation
Change of mayo criteria in UC patients after FMT.
Time frame: one year
Number of patients with adverse events after FMT.
Time frame: one year
No study locations are listed for this record.
This study is status unknown, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.